SPA
MRNS

Sherbrooke Park Advisers’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Sherbrooke Park Advisers’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-64,721
Closed -$585K – 1267
2024
Q1 		$585K Buy
+64,721
New +$585K 0.11% 311
2023
Q4 		– Sell
-17,539
Closed -$141K – 727
2023
Q3 		$141K Buy
+17,539
New +$141K 0.04% 428